FATE News and Press, Fate Therapeutics Inc. From 07/19/21

Biotech Penny Stocks & Small Caps Gain Ground After Cytokinetics Gets Boost On News When it comes to penny stocks or small-caps, in general, sector & industry trends can play a role. Broader markets and indexes like the S&P 500 ETF ( NYSE: SPY ) and Nasdaq ETF ( NASDAQ...

A dashboard with metrics in healthcare industries. Value and quality scores, and their evolution since last month. Focus on IDNA. A list of cheap stocks. For further details see: IDNA And Healthcare Dashboard For July

SAN DIEGO, July 16, 2021 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer, today announced that management will host a virtual event to highlight interim Phas...

SAN DIEGO, July 15, 2021 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer, today announced that the Company will host a conference call and live audio we...

Biotech Companies Like GT Biopharma & Fate Therapeutics Are In The Spotlight Thanks To Novel & Breakthrough Treatment Platforms The last year has seen plenty of trends emerge among retail investors and institutions alike. Obviously, the “meme stock” trend has taken...

janiecbros/E+ via Getty Images Biotech M&A is poised to heat up again as shares of the SPDR S&P Biotech’s (XBI) have fallen about 25% from their February highs, according to Jefferies. Biotech deals may pick up after a 3-6 month of a large "drawdown" and as prices "normalize" f...

Using the quarterly 13F filings we extract 50 consensus stocks from 40 large hedge funds, each fund with more than $3.5 billion in assets under management. After the Q1-2021 13F filings the consensus holdings are updated, 5 stocks were removed and 6 added from the universe now holding...

IDNA enables investors to benefit from advancements and commercialization opportunities of the genomics field. Compared to ARKG, this is more of a pure-play gene ETF and is also less volatile. On the cautionary side, with the progress being done, especially in CRISPR, more media f...

Penny Stocks Aren’t The Only Thing Grabbing Retail Attention Right Now Retail traders have dominated market headlines this year. Thanks to apps like Robinhood & Webull, smaller companies have gained momentum. But it isn’t just penny stocks on the docket right now. ...

Should Penny Stocks Be On Your List In 2021? Cancer stocks are some of the most popular among investors. Yes, we’re talking about companies in an industry working to tackle the second largest cause of death worldwide after cardiovascular disease. But we’re also talking...